Theramix develops therapeutics and diagnostics based on molecular imaging. We take a systems approach in our discovery by working on the targets in their native microenvironment. The discovery process begins with in vivo selection of targets, and only proceeds through the stages with positive imaging results. The efficiency is greatly improved by keeping the development on focus with visualization of the process. The major challenge is to have imaging techniques available to streamline with all stages of the development. We're creating a platform based on our proprietary imaging technology to meet such needs.
